Studies have demonstrated that EMT is an important factor in the development of pulmonary fibrosis, while inhibition of EMT with TGF-β inhibitors adequately ameliorates pulmonary fibrosis in mice [41]. Here, TGFB1 is linked to pulmonary fibrosis.